You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is A 45 year old female presents with the complaint of pain in the metacarpophalangeal, proximal interphalangeal and metatarsophalangeal joints of both right and left hands. Serology showed positive anti-CCP antibodies. She was placed on infliximab for control. Which of the following need to tested before starting treatment? and explain in detail?
Answer: d) PPD skin test* The patient is having rheumatoid arthritis which is diagnosed by the positive anti-CCP levels on serology.* Biological disease modifying anti rheumatoid drugs include following TNF a inhibitors: Infliximab, Etanercept, Adalimumab, Golimumab* Infliximab is chimeric monoclonal antibody while Adalimumab & Golimumab are human monoclonal antibodies.* Anti TNF agents are to be avoided in active infections and hypersensitivity reactions.* There is an increased risk of opportunistic infections and flare up of latent tuberculosis.* Hence obtaining a purified PPD skin test is a mandatory requirement for starting TNF a inhibitors.